StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PBYI

Puma Biotechnology, Inc.

PBYI Nasdaq Pharmaceutical Preparations EDGAR ↗
$7.69
-0.20 -2.53%

Key statistics

from XBRL data in SEC filings
Market cap
$391M
Revenue (TTM)
$227M
Net income (TTM)
$24.4M
EPS (TTM)
$0.48
P/E ratio
16.0
Dividend yield
Free cash flow
$41.7M
Cash
$36.2M
Total assets
$193M
Gross margin
52-week range
$3.05 – $8.75

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 16, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 10-Q/A Quarter ended 2025-03-31 Aug 7, 2025 8-K Amended charter or bylaws Jun 24, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Director or officer change May 9, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Sep 16, 2024 8-K Other events Aug 15, 2024 8-K Other events Aug 7, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Director or officer change; Shareholder vote results Jun 24, 2024 8-K Other events May 17, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Other events Mar 19, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Regulation FD disclosure Jan 18, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023 8-K Regulation FD disclosure Sep 26, 2023 8-K Amended charter or bylaws Aug 18, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 3, 2023 8-K Shareholder vote results Jun 15, 2023 10-Q Quarter ended 2023-03-31 May 4, 2023